GLP-1 medications like Ozempic are widely associated with health and appearance. But new survey data suggests a less discussed motivation: career advancement. A Sunlight.com survey of 1,000 U.S. adults who lost 10 or more pounds in the past two years finds that a significant share of GLP-1 users started the medication with professional goals in mind, and the data suggests it may be paying off.
Key Findings:
- 41% of GLP-1 users say professional or career advancement was a motivation for starting the medication.
- GLP-1 users are 50% more likely to have been promoted than those who lost weight through diet and exercise alone.
- 3 in 4 workers believe physical appearance directly impacts career advancement.
- Workers who lost weight specifically for career reasons got raises at three times the rate of those who lost weight for other reasons.
- Men are 53% more likely than women to cite career advancement as a motivation for weight loss, and they capture a disproportionate share of the professional payoff.
4 in 10 GLP-1 Users Say Career Advancement Motivated Their Decision to Start
Among respondents who used GLP-1 medication to lose weight, 41% cited professional or career advancement as a motivation for starting. One in three said career was a “major factor” in their decision. By comparison, only 27% of all respondents cited career as a motivation for their weight loss, making GLP-1 users 53% more likely to be career-motivated.
Among GLP-1 users, health concerns top the list of motivations at 77%, followed by personal confidence at 69% and medical recommendation at 43%. Career advancement comes next at 41%, ahead of dating at 33%. That makes career the leading non-health, non-clinical reason GLP-1 users give for starting the medication.
One in three survey respondents who lost weight used a GLP-1 medication (34%), indicating that these drugs now represent a significant share of the weight loss population, not a fringe group.
“Many patients on GLP-1 medications find an early boost in their confidence that spills over into many areas of their life, including career, relationships, family, and social life,” says Dr. Angela Tran, Sunlight’s Chief Medical Advisor, who is board-certified in internal and obesity medicine. “Compared to previously available medications approved for weight loss, GLP-1s often produce much earlier results upfront. Especially for individuals who have struggled with weight loss for many years, the feeling of almost overnight weight loss creates a sense of new hope they have never experienced before.”
GLP-1 Users Are 50% More Likely to Get Promoted Than Those Who Lost Weight Through Diet and Exercise
Among GLP-1 users, 31% received a promotion after losing weight, compared to roughly 20% of those who lost weight through diet and exercise alone.
GLP-1 users also reported being given more responsibilities (42%, compared to 32% overall), being included in more important meetings (33%, compared to 20% overall), and receiving a raise (25%, compared to roughly 22% for diet and exercise users).
Among workers who lost weight specifically for career reasons, 37% received a raise, compared to 12% of those who lost weight for other reasons. Nearly 1 in 5 GLP-1 users who cited career as a motivation were also promoted.
“Not only do patients experience the physical changes of losing weight, many have a significant internal shift in their identity and how they show up differently at work,” says Dr. Tran. “One of the benefits of GLP-1s is that it helps reduce food noise. As a consequence, patients feel more present, more engaging in meetings, more confident to contribute to conversations, and oftentimes feel more capable in problem-solving than ever before.”
3 in 4 Workers Say Physical Appearance Directly Impacts Career Advancement
More than three in four workers (77%) believe that physical appearance directly impacts career advancement, with 43% saying “definitely yes.”
Among those who said appearance “definitely” impacts career advancement, 26% received a raise after losing weight. Among those who said it “probably not,” 5% did.
Workers in tech and finance hold this belief at the highest rates (85% each), while government workers are least likely to agree (63%).
Nearly two in three workers (62%) say they are taken more seriously at work after losing weight, and 65% noticed career benefits within six months. Nearly 1 in 10 saw changes within a month.
“Patients often experience both: they change how they carry themselves, and how others perceive them changes,” says Dr. Tran. “With weight loss, patients often almost immediately experience less self-consciousness, more energy and more presence in conversations, and even subtle changes such as better posture, more eye contact, and improved appearance. There is a shift in willingness to take on new things they previously didn’t do before. Volunteering to lead new projects. Posing more insightful questions in meetings. The internal shift is then reinforced by how others perceive them.”
Men Are Driving the Ozempic-for-Career Trend, and Capturing More of the Payoff
Men are more likely to use GLP-1 medications (37% vs. 31% of women), more likely to cite career as a motivation for weight loss (32% vs. 21%), and more likely to be promoted after losing weight (22% vs. 14%).
Men are also more likely to receive a raise (20% vs. 16%) and to report all three outcomes together, a raise, a promotion, and being taken more seriously (7% of men vs. 4% of women). Twenty-five percent of men said career was a “major factor” in their weight loss decision, compared to 15% of women.
Among workers who were equally career-motivated, however, raise rates are nearly identical: 37% for men and 37% for women.
“Women, particularly in the workplace, often desire to be viewed as credible, confident, and capable of leading high-level positions just as well as men in the same position,” says Dr. Tran. “Men seek more performance and are driven by higher-level goal setting, with more of a focus on having the energy and stamina to handle higher-level job responsibilities. Both men and women often want more opportunities to share their known gifts and talents that come more readily apparent with confidence.”
Methodology
In March 2026, Sunlight.com surveyed 1,000 U.S. adults aged 18 and older who lost 10 or more pounds in the past two years. The sample was evenly balanced by gender (500 male, 500 female). Among respondents, 338 reported using GLP-1 medication as part of their weight loss. The survey was conducted via Pollfish. Quality checks were applied to identify and remove inattentive or invalid responses. The margin of error is +/-3 percentage points at the 95% confidence level. All data is self-reported. Percentages may not total 100% due to rounding or because respondents were permitted to select multiple responses where applicable.